197 related articles for article (PubMed ID: 18328272)
21. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
Beaumont K; Smith DA
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
[TBL] [Abstract][Full Text] [Related]
22. PowerMV: a software environment for molecular viewing, descriptor generation, data analysis and hit evaluation.
Liu K; Feng J; Young SS
J Chem Inf Model; 2005; 45(2):515-22. PubMed ID: 15807517
[TBL] [Abstract][Full Text] [Related]
23. A novel in silico approach to drug discovery via computational intelligence.
Hecht D; Fogel GB
J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
[TBL] [Abstract][Full Text] [Related]
24. Drugs targeting protein-protein interactions.
Chène P
ChemMedChem; 2006 Apr; 1(4):400-11. PubMed ID: 16892375
[TBL] [Abstract][Full Text] [Related]
25. Preclinical formulations for discovery and toxicology: physicochemical challenges.
Neervannan S
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):715-31. PubMed ID: 17014391
[TBL] [Abstract][Full Text] [Related]
26. Snapshot PK: a rapid rodent in vivo preclinical screening approach.
Liu B; Chang J; Gordon WP; Isbell J; Zhou Y; Tuntland T
Drug Discov Today; 2008 Apr; 13(7-8):360-7. PubMed ID: 18405850
[TBL] [Abstract][Full Text] [Related]
27. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE
Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
[TBL] [Abstract][Full Text] [Related]
28. [Strategy of molecular drug design: hits, leads and drug candidates].
Guo ZR
Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
[TBL] [Abstract][Full Text] [Related]
29. New roles for structure in biology and drug discovery.
Russell RB; Eggleston DS
Nat Struct Biol; 2000 Nov; 7 Suppl():928-30. PubMed ID: 11103989
[No Abstract] [Full Text] [Related]
30. Unfinished business: target-based drug discovery.
Brown D
Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
[TBL] [Abstract][Full Text] [Related]
31. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
32. Developing a drug-like natural product library.
Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
[TBL] [Abstract][Full Text] [Related]
33. Nuclear magnetic resonance in target profiling and compound file enhancement.
Sun C; Hajduk PJ
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):463-70. PubMed ID: 16889229
[TBL] [Abstract][Full Text] [Related]
34. [Problems in preclinical pharmacology when deciding on suitable animal species and animal tests models].
Hoefke W
Arzneimittelforschung; 1977 Feb; 27(2A):223-8. PubMed ID: 577167
[TBL] [Abstract][Full Text] [Related]
35. Natural products as a robust source of new drugs and drug leads: past successes and present day issues.
Rishton GM
Am J Cardiol; 2008 May; 101(10A):43D-49D. PubMed ID: 18474274
[TBL] [Abstract][Full Text] [Related]
36. New screening tools for lead compound identification.
Sawyer TK
Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
[No Abstract] [Full Text] [Related]
37. A multiplexed approach to hit finding.
Slack M; Winkler D; Krämer J; Hesterkamp T
Curr Opin Drug Discov Devel; 2009 May; 12(3):351-7. PubMed ID: 19396736
[TBL] [Abstract][Full Text] [Related]
38. Dissimilarity-based approaches to compound acquisition.
Lajiness M; Watson I
Curr Opin Chem Biol; 2008 Jun; 12(3):366-71. PubMed ID: 18423415
[TBL] [Abstract][Full Text] [Related]
39. Introduction of an information-theoretic method to predict recovery rates of active compounds for Bayesian in silico screening: theory and screening trials.
Vogt M; Bajorath J
J Chem Inf Model; 2007; 47(2):337-41. PubMed ID: 17302401
[TBL] [Abstract][Full Text] [Related]
40. Correct assessment of new compounds using in vivo screening models can reduce false positives.
Bueters TJ; Hoogstraate J; Visser SA
Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
